Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
US9932313B2 · kind B2 · utility
1Cited by
17References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2017 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Feb 1, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides pyrazolyl guanidine compounds that inhibit F1Fo-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.